APOPTOSIS-RESISTANT PHENOTYPE SELECTED BY ALTERNATING EXPOSURE TO CAMPTOTHECIN AND ETOPOSIDE
Citation
M. Kubota et al., APOPTOSIS-RESISTANT PHENOTYPE SELECTED BY ALTERNATING EXPOSURE TO CAMPTOTHECIN AND ETOPOSIDE, Experimental cell research, 235(1), 1997, pp. 138-144
Categorie Soggetti
Oncology,"Cell Biology
SICI code
0014-4827(1997)235:1<138:APSBAE>2.0.ZU;2-Q
Abstract
We selected an apoptosis-resistant subline (VC-33) in a human promyelo
cytic leukemia cell line, HL-60, by alternating exposure to camptothec
in (CPT) and etoposide (VP-16). When wild-type (WT) and VC-33 cells we
re incubated with various concentrations of either CPT or VP-16 for 4
h, VC-33 showed several-fold resistance to apoptosis induced by these
agents in comparison with WT cells, VC-33 cells also exhibited cross-r
esistance to apoptosis induced by 1-beta-D-arabinofuranosylcytosine, h
ydroxyurea, a calcium ionophore (A23187), cycloheximide, or UV irradia
tion. The levels of protein-DNA cross-linking induced by CPT or VP-16,
and the amounts of ara-CTP generation, tended to be smaller in VC-33
cells, but the difference was not sufficient to explain the difference
in the sensitivity to apoptosis. The initial rise of intracellular ca
lcium ions with A23181 and the expression of P-glycoprotein, Bcl-2, an
d Bcl-XL were comparable between WT and VC-33 cells. This mutant may r
epresent a new phenotype of resistance to apoptosis induced by a varie
ty of agents, and may thus be useful in the study of the mechanisms of
apoptosis. (C) 1997 Academic Press.